You can buy or sell Celgene and other stocks, options, ETFs, and crypto commission-free!
Celgene Corporation Common Stock, also called Celgene, is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. Read More The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
Summit, New Jersey
52 Week High
52 Week Low
Bristol-Myers Squibb wins antitrust approval to buy Celgene, but must divest psoriasis drugFILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 20
Expected Jan 30